-
1
-
-
0032916601
-
Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study
-
Aarsland, D., Larsen, J.P., Cummins, J.L. and Laake, K. ( 1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56: 595-601.
-
(1999)
Arch Neurol
, vol.56
, pp. 595-601
-
-
Aarsland, D.1
Larsen, J.P.2
Cummins, J.L.3
Laake, K.4
-
2
-
-
0035000813
-
A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia
-
Aarsland, D., Ballard, C., Larsen, J.P. and McKeith, I. ( 2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 16: 528-536.
-
(2001)
Int J Geriatr Psychiatry
, vol.16
, pp. 528-536
-
-
Aarsland, D.1
Ballard, C.2
Larsen, J.P.3
McKeith, I.4
-
3
-
-
0033895282
-
Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study
-
Aarsland, D., Larsen, J.P., Tandberg, E. and Laake, K. ( 2000) Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 48: 938-942.
-
(2000)
J Am Geriatr Soc
, vol.48
, pp. 938-942
-
-
Aarsland, D.1
Larsen, J.P.2
Tandberg, E.3
Laake, K.4
-
4
-
-
0030795988
-
Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group
-
Arvanitis, L.A. and Miller, B.G. ( 1997) Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 42: 233-246.
-
(1997)
Biol Psychiatry
, vol.42
, pp. 233-246
-
-
Arvanitis, L.A.1
Miller, B.G.2
-
5
-
-
0037253385
-
Reality monitoring and visual hallucinations in Parkinson's disease
-
Barnes, J., Boubert, L., Harris, J., Lee, A. and David, A.S. ( 2003) Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia 41: 565-574.
-
(2003)
Neuropsychologia
, vol.41
, pp. 565-574
-
-
Barnes, J.1
Boubert, L.2
Harris, J.3
Lee, A.4
David, A.S.5
-
6
-
-
0034990077
-
Visual hallucinations in Parkinson's disease: a review and phenomenological survey
-
Barnes, J. and David, A.S. ( 2001) Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 70: 727-733.
-
(2001)
J Neurol Neurosurg Psychiatry
, vol.70
, pp. 727-733
-
-
Barnes, J.1
David, A.S.2
-
7
-
-
0029878084
-
ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US SEROQUEL Study Group
-
Borison, R.L., Arvanitis, L.A. and Miller, B.G. ( 1996) ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US SEROQUEL Study Group. J Clin Psychopharmacol 16: 158-169.
-
(1996)
J Clin Psychopharmacol
, vol.16
, pp. 158-169
-
-
Borison, R.L.1
Arvanitis, L.A.2
Miller, B.G.3
-
8
-
-
0037039263
-
Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease
-
Brandstadter, D. and Oertel, W.H. ( 2002) Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology 58: 160-161.
-
(2002)
Neurology
, vol.58
, pp. 160-161
-
-
Brandstadter, D.1
Oertel, W.H.2
-
9
-
-
84993716813
-
Atypical antipsychotic drugs and stroke
-
Committee on Safety of Medicines 9 March 2004. Available at (accessed 26 April 2010)
-
Committee on Safety of Medicines (2004) Atypical antipsychotic drugs and stroke. Latest news, 9 March 2004. Available at: https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=100974 (accessed 26 April 2010).
-
(2004)
Latest news
-
-
-
10
-
-
0033545523
-
Managing psychosis in patients with Parkinson's disease
-
Cummings, J.L. ( 1999) Managing psychosis in patients with Parkinson's disease. N Engl J Med 340: 801-803.
-
(1999)
N Engl J Med
, vol.340
, pp. 801-803
-
-
Cummings, J.L.1
-
11
-
-
0027985334
-
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia
-
Cummings, J.L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D.A. and Gornbein, J. ( 1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314.
-
(1994)
Neurology
, vol.44
, pp. 2308-2314
-
-
Cummings, J.L.1
Mega, M.2
Gray, K.3
Rosenberg-Thompson, S.4
Carusi, D.A.5
Gornbein, J.6
-
12
-
-
10044283107
-
Rivastigmine for dementia associated with Parkinson's disease
-
Emre, M., Aarsland, D., Albanese, A., Byrne, E.J., Deuschl, G., de Deyn, P.P. et al. (2004) Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 351: 2509-2518.
-
(2004)
N Engl J Med
, vol.351
, pp. 2509-2518
-
-
Emre, M.1
Aarsland, D.2
Albanese, A.3
Byrne, E.J.4
Deuschl, G.5
de Deyn, P.P.6
-
13
-
-
0001505068
-
Seroquel” treatment of psychosis in parkinsonism [abstract]
-
Evatt, M.L., Jewart, D. and Juncos, J.L. ( 1996) “Seroquel” treatment of psychosis in parkinsonism [abstract]. Mov Disord 11: 595.
-
(1996)
Mov Disord
, vol.11
, pp. 595
-
-
Evatt, M.L.1
Jewart, D.2
Juncos, J.L.3
-
15
-
-
0000224448
-
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale”
-
Fahn, S., Marsden, C.D., Calne, D.B. and Goldstein, M. (eds) (1987). “Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale”, Recent Developments Parkinson's Dis, 11: pp. 153-163.
-
(1987)
Recent Developments Parkinson's Dis
, vol.11
, pp. S.-163
-
-
Fahn1
Marsden, C.D.2
Calne, D.B.3
Goldstein, M.4
-
16
-
-
74149083011
-
(2010) Epidemiology of psychosis in Parkinson's disease
-
Fenelon, G. and Alves, G. (2010) Epidemiology of psychosis in Parkinson's disease. J Neurol Sci 289: 12-17.
-
J Neurol Sci
, vol.289
, pp. 12-17
-
-
Fenelon, G.1
Alves, G.2
-
17
-
-
0033453264
-
Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
-
Fernandez, H.H., Friedman, J.H., Jacques, C. and Rosenfeld, M. ( 1999) Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 14: 484-487.
-
(1999)
Mov Disord
, vol.14
, pp. 484-487
-
-
Fernandez, H.H.1
Friedman, J.H.2
Jacques, C.3
Rosenfeld, M.4
-
18
-
-
70450214108
-
(2009) Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study
-
Fernandez, H.H., Okun, M.S., Rodriguez, R.L., Malaty, I.A., Romrell, J., Sun, A. et al. (2009) Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study. Int J Neurosci 119: 2196-2205.
-
Int J Neurosci
, vol.119
, pp. 2196-2205
-
-
Fernandez, H.H.1
Okun, M.S.2
Rodriguez, R.L.3
Malaty, I.A.4
Romrell, J.5
Sun, A.6
-
19
-
-
0038485957
-
Long-term outcome of quetiapine use for psychosis among Parkinsonian patients
-
Fernandez, H.H., Trieschmann, M.E., Burke, M.A., Jacques, C. and Friedman, J.H. ( 2003) Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Mov Disord 18: 510-514.
-
(2003)
Mov Disord
, vol.18
, pp. 510-514
-
-
Fernandez, H.H.1
Trieschmann, M.E.2
Burke, M.A.3
Jacques, C.4
Friedman, J.H.5
-
20
-
-
0033549287
-
Clozapine in drug-induced psychosis in Parkinson's disease
-
French Clozapine Parkinson Study Group
-
French Clozapine Parkinson Study Group (1999 ) Clozapine in drug-induced psychosis in Parkinson's disease. Lancet 353: 2041.
-
(1999)
Lancet
, vol.353
, pp. 2041
-
-
-
21
-
-
0031753772
-
Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease
-
Friedberg, G., Zoldan, J., Weizman, A. and Melamed, E. ( 1998) Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol 21: 280-284.
-
(1998)
Clin Neuropharmacol
, vol.21
, pp. 280-284
-
-
Friedberg, G.1
Zoldan, J.2
Weizman, A.3
Melamed, E.4
-
22
-
-
33846447413
-
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
-
Friedman, J.H., Berman, R.M., Goetz, C.G., Factor, S.A., Ondo, W.G., Wojcieszek, J. et al. (2006) Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord 21: 2078-2208.
-
(2006)
Mov Disord
, vol.21
, pp. 2078-2208
-
-
Friedman, J.H.1
Berman, R.M.2
Goetz, C.G.3
Factor, S.A.4
Ondo, W.G.5
Wojcieszek, J.6
-
23
-
-
0034107042
-
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
-
Friedman, J.H. and Factor, S.A. ( 2000) Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 15: 201-211.
-
(2000)
Mov Disord
, vol.15
, pp. 201-211
-
-
Friedman, J.H.1
Factor, S.A.2
-
24
-
-
0037366161
-
[Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease]
-
Gimenez-Roldan, S., Navarro, E. and Mateo, D. ( 2003) [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease]. Rev Neurol 36: 401-404.
-
(2003)
Rev Neurol
, vol.36
, pp. 401-404
-
-
Gimenez-Roldan, S.1
Navarro, E.2
Mateo, D.3
-
25
-
-
0035846632
-
Prospective longitudinal assessment of hallucinations in Parkinson's disease
-
Goetz, C.G., Leurgans, S., Pappert, E.J., Raman, R. and Stemer, A.B. ( 2001) Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 57: 2078-2082.
-
(2001)
Neurology
, vol.57
, pp. 2078-2082
-
-
Goetz, C.G.1
Leurgans, S.2
Pappert, E.J.3
Raman, R.4
Stemer, A.B.5
-
26
-
-
0028901771
-
Mortality and hallucinations in nursing home patients with advanced Parkinson's disease
-
Goetz, C.G. and Stebbins, G.T. ( 1995) Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 45: 669-671.
-
(1995)
Neurology
, vol.45
, pp. 669-671
-
-
Goetz, C.G.1
Stebbins, G.T.2
-
28
-
-
0001179622
-
Quetiapine improves psychotic symptoms associated with Parkinson's disease
-
Suppl.
-
Juncos, J.L., Arvanitis, L., Yeung, P., Jewart, R.D. and Nemeroff, C. ( 1999) Quetiapine improves psychotic symptoms associated with Parkinson's disease. Neurology 52(6 Suppl. 2): A262.
-
(1999)
Neurology
, vol.52
, Issue.6
, pp. A262
-
-
Juncos, J.L.1
Arvanitis, L.2
Yeung, P.3
Jewart, R.D.4
Nemeroff, C.5
-
29
-
-
2342443881
-
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease
-
Juncos, J.L., Roberts, V.J., Evatt, M.L., Jewart, R.D., Wood, C.D., Potter, L.S. et al. (2004) Quetiapine improves psychotic symptoms and cognition in Parkinson's disease. Mov Disord 19: 29-35.
-
(2004)
Mov Disord
, vol.19
, pp. 29-35
-
-
Juncos, J.L.1
Roberts, V.J.2
Evatt, M.L.3
Jewart, R.D.4
Wood, C.D.5
Potter, L.S.6
-
30
-
-
0028331326
-
The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research
-
Kerwin, R.W. ( 1994) The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. Br J Psychiatry 164: 141-148.
-
(1994)
Br J Psychiatry
, vol.164
, pp. 141-148
-
-
Kerwin, R.W.1
-
31
-
-
34247487794
-
Quetiapine for agitation or psychosis in patients with dementia and Parkinsonism
-
Kurlan, R., Cummings, J., Raman, R. and Thal, L. ( 2007) Quetiapine for agitation or psychosis in patients with dementia and Parkinsonism. Neurology 68: 1356-1363.
-
(2007)
Neurology
, vol.68
, pp. 1356-1363
-
-
Kurlan, R.1
Cummings, J.2
Raman, R.3
Thal, L.4
-
32
-
-
1442300046
-
Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease
-
Mancini, F., Tassorelli, C., Martignoni, E., Moglia, A., Nappi, G., Cristina, S. et al. (2004) Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. Clin Neuropharmacol 27: 33-37.
-
(2004)
Clin Neuropharmacol
, vol.27
, pp. 33-37
-
-
Mancini, F.1
Tassorelli, C.2
Martignoni, E.3
Moglia, A.4
Nappi, G.5
Cristina, S.6
-
33
-
-
33750910746
-
Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis
-
Merims, D., Balas, M., Peretz, C., Shabtai, H. and Giladi, N. ( 2006) Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Clin Neuropharmacol 29: 331-337.
-
(2006)
Clin Neuropharmacol
, vol.29
, pp. 331-337
-
-
Merims, D.1
Balas, M.2
Peretz, C.3
Shabtai, H.4
Giladi, N.5
-
34
-
-
53949112680
-
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2008) Extrapyramidal side-effects of antipsychotics in a randomised trial
-
Miller, D.D., Caroff, S.N., Davis, S.M., Rosenheck, R.A., McEvoy, J.P., Saltz, B.L. et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2008) Extrapyramidal side-effects of antipsychotics in a randomised trial. Br J Psychiatry 193: 279-288.
-
Br J Psychiatry
, vol.193
, pp. 279-288
-
-
Miller, D.D.1
Caroff, S.N.2
Davis, S.M.3
Rosenheck, R.A.4
McEvoy, J.P.5
Saltz, B.L.6
-
35
-
-
33646107153
-
Quality Standards Subcommittee of the American Academy of Neurology Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Miyasaki, J.M., Shannon, K., Voon, V., Ravina, B., Kleiner-Fisman, G. and Anderson, K. Quality Standards Subcommittee of the American Academy of Neurology Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66: 996-1002.
-
Neurology
, vol.66
, pp. 996-1002
-
-
Miyasaki, J.M.1
Shannon, K.2
Voon, V.3
Ravina, B.4
Kleiner-Fisman, G.5
Anderson, K.6
-
36
-
-
20844433549
-
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis
-
Morgante, L., Epifanio, A., Spina, E., Zappia, M., Di Rosa, A.E., Marconi, R. et al. (2004) Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. Clin Neuropharmacol 27: 153-156.
-
(2004)
Clin Neuropharmacol
, vol.27
, pp. 153-156
-
-
Morgante, L.1
Epifanio, A.2
Spina, E.3
Zappia, M.4
Di Rosa, A.E.5
Marconi, R.6
-
37
-
-
46849104824
-
A semi-structured interview to assess visual hallucinations in older people
-
Mosimann, U.P., Collerton, D., Dudley, R., Meyer, T.D., Graham, G., Dean, J.L. et al. (2008) A semi-structured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry 23: 712-718.
-
(2008)
Int J Geriatr Psychiatry
, vol.23
, pp. 712-718
-
-
Mosimann, U.P.1
Collerton, D.2
Dudley, R.3
Meyer, T.D.4
Graham, G.5
Dean, J.L.6
-
38
-
-
0036764866
-
Olanzapine treatment for dopaminergic-induced hallucinations
-
Ondo, W.G., Levy, J.K., Vuong, K.D., Hunter, C. and Jankovic, J. ( 2002) Olanzapine treatment for dopaminergic-induced hallucinations. Mov Disord 17: 1031-1035.
-
(2002)
Mov Disord
, vol.17
, pp. 1031-1035
-
-
Ondo, W.G.1
Levy, J.K.2
Vuong, K.D.3
Hunter, C.4
Jankovic, J.5
-
39
-
-
26444597010
-
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
-
Ondo, W.G., Tintner, R., Voung, K.D., Lai, D. and Ringholz, G. ( 2005) Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. Mov Disord 20: 958-963.
-
(2005)
Mov Disord
, vol.20
, pp. 958-963
-
-
Ondo, W.G.1
Tintner, R.2
Voung, K.D.3
Lai, D.4
Ringholz, G.5
-
40
-
-
0002164061
-
-
ECDEU Assessment Manual for Psychopharmacology (Revised Edition) Rockville, MD: USNIH, Psychopharmacology Research Branch
-
Overall, J. and Gorham, D. ( 1976) Brief psychiatric rating scale (BPRS) 1962, In: Guy, W. (ed.). ECDEU Assessment Manual for Psychopharmacology (Revised Edition), Rockville, MD : USNIH, Psychopharmacology Research Branch, pp. 158-169.
-
(1976)
Brief psychiatric rating scale (BPRS) 1962
, pp. 158-169
-
-
Overall, J.1
Gorham, D.2
Guy, W.3
-
41
-
-
0033545542
-
Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease
-
Parkinson Study Group
-
Parkinson Study Group (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med 340: 757-763.
-
(1999)
N Engl J Med
, vol.340
, pp. 757-763
-
-
-
42
-
-
0034684139
-
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial
-
Parkinson Study Group
-
Parkinson Study Group (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. JAMA 284: 1931-1938.
-
(2000)
JAMA
, vol.284
, pp. 1931-1938
-
-
-
43
-
-
32844465773
-
The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview
-
Prohorov, T., Klein, C., Miniovitz, A., Dobronevsky, E. and Rabey, J.M. ( 2006) The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview. J Neurol 253: 171-175.
-
(2006)
J Neurol
, vol.253
, pp. 171-175
-
-
Prohorov, T.1
Klein, C.2
Miniovitz, A.3
Dobronevsky, E.4
Rabey, J.M.5
-
44
-
-
34147140466
-
Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months’ duration
-
Rabey, J.M., Prokhorov, T., Miniovitz, A., Dobronevsky, E. and Klein, C. ( 2007) Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months’ duration. Mov Disord 22: 313-318.
-
(2007)
Mov Disord
, vol.22
, pp. 313-318
-
-
Rabey, J.M.1
Prokhorov, T.2
Miniovitz, A.3
Dobronevsky, E.4
Klein, C.5
-
45
-
-
0034682308
-
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group
-
Rascol, O., Brooks, D.J., Korczyn, A.D., de Deyn, P.P., Clarke, C.E. and Lang, A.E. ( 2000) A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 342: 1484-1491.
-
(2000)
N Engl J Med
, vol.342
, pp. 1484-1491
-
-
Rascol, O.1
Brooks, D.J.2
Korczyn, A.D.3
de Deyn, P.P.4
Clarke, C.E.5
Lang, A.E.6
-
46
-
-
0036652714
-
The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia
-
Reddy, S., Factor, S.A., Molho, E.S. and Feustel, P.J. ( 2002) The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Mov Disord 17: 676-681.
-
(2002)
Mov Disord
, vol.17
, pp. 676-681
-
-
Reddy, S.1
Factor, S.A.2
Molho, E.S.3
Feustel, P.J.4
-
47
-
-
26844538114
-
Risk of death with atypical antipsychotic drug treatment for dementia. Meta-analysis of randomized placebo-controlled trials
-
Schneider, L.S., Dagerman, K.S. and Insel, P. ( 2005) Risk of death with atypical antipsychotic drug treatment for dementia. Meta-analysis of randomized placebo-controlled trials. JAMA 294: 1934-1943.
-
(2005)
JAMA
, vol.294
, pp. 1934-1943
-
-
Schneider, L.S.1
Dagerman, K.S.2
Insel, P.3
-
48
-
-
70449698819
-
(2009) A randomized controlled trial of quetiapine for psychosis in Parkinson's disease
-
Shotbolt, P., Samuel, M., Fox, C. and David, A.S. (2009) A randomized controlled trial of quetiapine for psychosis in Parkinson's disease. Neuropsychiatr Dis Treat 5: 327-332.
-
Neuropsychiatr Dis Treat
, vol.5
, pp. 327-332
-
-
Shotbolt, P.1
Samuel, M.2
Fox, C.3
David, A.S.4
-
49
-
-
0030920294
-
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo
-
Small, J.G., Hirsch, S.R., Arvanitis, L.A., Miller, B.G. and Link, C.G. ( 1997) Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry 54: 549-557.
-
(1997)
Seroquel Study Group. Arch Gen Psychiatry
, vol.54
, pp. 549-557
-
-
Small, J.G.1
Hirsch, S.R.2
Arvanitis, L.A.3
Miller, B.G.4
Link, C.G.5
-
50
-
-
44949176630
-
Dopamine agonist therapy in early Parkinson's disease (review)
-
Stowe, R.L., Ives, N.J., Clarke, C.E., van Hilten, J., Ferreira, J., Hawker, R.J. et al. (2008) Dopamine agonist therapy in early Parkinson's disease (review). Cochrane Database Syst Rev 2: CD006564.
-
(2008)
Cochrane Database Syst Rev
, vol.2
, pp. CD006564
-
-
Stowe, R.L.1
Ives, N.J.2
Clarke, C.E.3
van Hilten, J.4
Ferreira, J.5
Hawker, R.J.6
-
51
-
-
0033955214
-
Efficacy of quetiapine in Parkinson's patients with psychosis
-
Targum, S.D. and Abbott, J.L. ( 2000) Efficacy of quetiapine in Parkinson's patients with psychosis. J Clin Psychopharmacol 20: 54-60.
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 54-60
-
-
Targum, S.D.1
Abbott, J.L.2
-
52
-
-
0034901147
-
Management of psychosis in Parkinson's disease
-
Wolters, E.C. and Berendse, H.W. ( 2001) Management of psychosis in Parkinson's disease. Curr Opin Neurol 14: 499-504.
-
(2001)
Curr Opin Neurol
, vol.14
, pp. 499-504
-
-
Wolters, E.C.1
Berendse, H.W.2
|